Literature DB >> 6611071

Localization of m-iodo(131I)benzylguanidine in neuroblastoma.

R S Hattner, J P Huberty, B L Engelstad, C A Gooding, A R Ablin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6611071     DOI： 10.2214/ajr.143.2.373

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  10 in total

1.  Nuclear medicine: metaiodobenzylguanidine in the diagnosis of pheochromocytoma and neuroblastoma.

Authors:  R S Hattner
Journal:  West J Med       Date:  1988-04

Review 2.  Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.

Authors:  Egesta Lopci; Arturo Chiti; Maria Rita Castellani; Giovanna Pepe; Lidija Antunovic; Stefano Fanti; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

Review 3.  Imaging of neuroblastoma: an overview.

Authors:  A Bousvaros; D R Kirks; H Grossman
Journal:  Pediatr Radiol       Date:  1986

Review 4.  Where are we with nuclear medicine in pediatrics?

Authors:  H R Nadel
Journal:  Eur J Nucl Med       Date:  1995-12

Review 5.  Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.

Authors:  Oliver Gimm; Catherine DeMicco; Aurel Perren; Francesco Giammarile; Martin K Walz; Laurent Brunaud
Journal:  Langenbecks Arch Surg       Date:  2011-11-29       Impact factor: 3.445

6.  131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.

Authors:  S Hibi; S Todo; S Imashuku; T Miyazaki
Journal:  Pediatr Radiol       Date:  1987

7.  Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.

Authors:  Kenneth F Koral; John P Huberty; Bill Frame; Katherine K Matthay; John M Maris; Denise Regan; Daniel Normolle; Gregory A Yanik
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-06       Impact factor: 9.236

8.  Radioiodinated metaiodobenzylguanidine in neuroblastoma: influence of high dose on tumour site detection.

Authors:  F Giammarile; J Lumbroso; M Ricard; B Aubert; O Hartmann; M Schlumberger; C Parmentier
Journal:  Eur J Nucl Med       Date:  1995-10

Review 9.  The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites.

Authors:  K D Bagshawe
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

10.  Targeted radionuclide therapy.

Authors:  Devrim Ersahin; Indukala Doddamane; David Cheng
Journal:  Cancers (Basel)       Date:  2011-10-11       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.